Emcure Pharmaceuticals

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue2,1042,2732,3652,4742,583
Expenses1,8101,9322,0132,1432,189
EBITDA420.47478.60494.60483.55534.57
Operating Profit317.52373.96351.77387.58425.07
Profit Before Tax290.76341.42313.79341.18393.52
Net Profit214.79251.37231.37243.74292.49
Financial Ratios
Operating Profit Margin19.85%21.09%19.31%20.00%20.72%
Net Profit Margin9.97%10.73%10.84%9.57%11.39%
Earning Per Share (Diluted)10.9212.8512.1612.8415.50
Dividends Per Share0.000.000.000.000.00